推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis …

[PDF] from ascopubs.orgEA Perez, EH Romond, VJ Suman… - Journal of Clinical …, 2011 - jco.ascopubs.org
Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong-Hyeon Jeong, Nancy E. Davidson,
Charles E. Geyer Jr, Silvana Martino, Eleftherios P. Mamounas, Peter A. Kaufman, and Norman
Wolmark Edith A. Perez, Mayo Clinic, Jackson- ville, FL; Edward H. Romond. University of ...

… -blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2–negative, …

[HTML] from jcojournal.orgNJ Robert, V Diéras, J Glaspy… - Journal of Clinical …, 2011 - jcojournal.org
Presented in part at the 45th Annual Meeting of the American Society for Clinical Oncology, May
29-June 2, 2009, Orlando, FL, and at the 15th Congress of the European Cancer Organisation
and 34th Congress of the European Society for Medical Oncology Multidisciplinary ...
Cited by 161 - Related articles - All 7 versions

Novel functions of individual epidermal growth factor receptor autophosphorylation sites in receptor regulation and signal transduction

DR Emlet - 2011 - gradworks.umi.com
The epidermal growth factor receptor (EGFR) is the prototypic member of the receptor protein
tyrosine kinase (RPTK) family of proteins, and it plays an essential role in both normal and neoplastic
signal transduction in many cell types. Critical for the specificity of signaling from the ...
Cached - All 2 versions

Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor

O Gonzalez-Perez, A Alvarez-Buylla - Brain Research Reviews, 2011 - Elsevier
Demyelinating diseases are characterized by an extensive loss of oligodendrocytes and myelin
sheaths from axolemma. These neurological disorders are a common cause of disability in young
adults, but so far, there is no effective treatment against them. It has been suggested that ...
Cited by 1 - Related articles - All 2 versions

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression‐free survival in patients with HER2‐positive metastatic …

A Lipton, K Leitzel, SM Ali, W Carney, G Platek… - Cancer, 2011 - Wiley Online Library
Changes in serum human epidermal growth factor receptor 2 (HER2) levels associated with
clinical outcomes, including objective response rate, progression-free survival (PFS), and overall
survival have been reported in patients with metastatic breast cancer (MBC) receiving ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451